XOOMAR

Upexi (UPXI)

Upexi on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as finance services.

Download CSV

11.7M

Short interest

settlement 2026-10-15

5.3

Days to cover

+3.1 days vs prior

42.9%

Short share of volume

2026-11-02

60,114

Fails to deliver

settlement 2026-10-09

Wed 11 Nov

Next earnings

estimated date

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in UPXI is 11,720,613 shares, down 3,474,415 shares over the last month. Over the last 48 readings it ranged from 8,697 shares (15 January 2025) to 19,543,293 shares (13 March 2026). At the reported average volume of 2.2M shares a day that is 5.3 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/upxi" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-1511,720,613-5.9%2,189,8195.35
2026-09-3012,453,498-18.0%5,662,8332.20
2026-09-1515,195,028+2.8%3,737,6774.07
2026-08-3114,776,077-2.0%4,442,3873.33
2026-08-1415,076,502-2.8%939,70316.04
2026-07-3115,513,032-7.7%900,59017.23
2026-07-1516,806,308+0.4%1,733,9609.69
2026-06-3016,734,871-1.9%2,395,5186.99
2026-06-1517,067,869+6.9%2,376,7447.18
2026-05-2915,972,841-1.0%2,521,3086.34
2026-05-1516,129,909-11.3%3,768,6624.28
2026-04-3018,191,777+1.2%3,103,2425.86
2026-04-1517,977,160-6.2%2,818,3906.38
2026-03-3119,160,529-2.0%6,428,2572.98
2026-03-1319,543,293+8.8%9,027,6892.16
2026-02-2717,962,288+44.6%4,712,4903.81
2026-02-1312,420,553+3.0%4,734,7222.62
2026-01-3012,053,867+16.3%2,969,9704.06
2026-01-1510,364,337-2.1%4,900,3252.12
2025-12-3110,590,242+14.1%3,737,8882.83
2025-12-159,278,168-8.6%3,664,0502.53
2025-11-2810,147,641+9.8%5,338,4581.90
2025-11-149,242,734-14.8%5,473,4471.69
2025-10-3110,853,775+20.6%3,790,8442.86
2025-10-158,996,729-41.9%5,635,3981.60
2025-09-3015,483,497+24.9%5,319,3762.91
2025-09-1512,399,217+128.7%5,737,6292.16
2025-08-295,422,062-50.6%6,116,7271.00
2025-08-1510,975,313+65.4%9,608,0831.14
2025-07-316,636,098+392.9%15,852,9331.00
2025-07-151,346,207+13.6%7,426,4661.00
2025-06-301,185,309+142.7%2,788,5541.00
2025-06-13488,463+63.1%345,7681.41
2025-05-30299,515+30.3%406,3251.00
2025-05-15229,939-45.4%765,0461.00
2025-04-30420,986+590.2%13,222,3751.00
2025-04-1560,997+119.3%99,4781.00
2025-03-3127,811-29.1%11,5942.40
2025-03-1439,247+89.0%124,4581.00
2025-02-2820,761-44.0%110,9541.00
2025-02-1437,086+0.8%89,0211.00
2025-01-3136,807+323.2%377,2721.00
2025-01-158,697-47.0%26,7861.00
2024-12-3116,410-20.6%68,9421.00
2024-12-1320,658+53.9%103,1631.00
2024-11-2913,420-63.1%200,7831.00
2024-11-1536,404-78.2%196,9501.00
2024-10-31166,746+835.9%4,315,2831.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of UPXI volume is 42.9%, down 2.4 points over the last five sessions. Over the last 30 readings it ranged from 22.5% (28 October 2026) to 73.0% (16 October 2026). The latest reading is 2.5 points below the 30-session average of 45.4%, on 451K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-02194K451K42.9%5,715
2026-10-30375K945K39.7%1,722
2026-10-29225K345K65.3%0
2026-10-2880K358K22.5%0
2026-10-27400K1.0M38.3%0
2026-10-26288K635K45.3%750
2026-10-23290K792K36.6%0
2026-10-22448K1.1M39.4%50,501
2026-10-21904K1.9M48.7%0
2026-10-20588K883K66.6%184
2026-10-19574K966K59.5%126,041
2026-10-16794K1.1M73.0%62,492
2026-10-151.0M2.2M45.9%2,031
2026-10-14499K1.1M46.1%1,750
2026-10-13172K545K31.5%400
2026-10-12590K1.3M44.0%700
2026-10-09347K593K58.5%0
2026-10-08571K1.7M33.2%7,577
2026-10-07926K2.4M38.8%8,879
2026-10-06427K1.1M38.1%0
2026-10-05563K1.2M47.1%4,077
2026-10-02444K1.1M40.9%0
2026-10-01591K1.3M46.4%40
2026-09-30506K893K56.6%0
2026-09-29700K1.7M40.7%0
2026-09-28943K2.2M42.4%4,207
2026-09-251.4M3.4M41.6%16,805
2026-09-241.5M3.0M50.5%13,913
2026-09-231.1M2.9M39.5%0
2026-09-221.4M3.2M43.2%6,570

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 9 October 2026, the fails-to-deliver balance in UPXI is 60,114 shares, up 53,566 shares over the last settlement date. Over the last 30 readings it ranged from 24 shares (15 September 2026) to 777,729 shares (26 August 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-10-0960,114$1.08$65K
2026-10-086,548$1.08$7K
2026-10-06314$1.15$361
2026-10-01121$1.14$138
2026-09-2916,833$1.19$20K
2026-09-28171,056$1.23$210K
2026-09-253,290$1.17$4K
2026-09-242,640$1.17$3K
2026-09-21492,991$1.19$587K
2026-09-1785,245$1.05$90K
2026-09-164,636$1.04$5K
2026-09-1524$1.10$26
2026-09-11296$0.99$293
2026-09-101,011$1.04$1K
2026-09-0896$1.07$103
2026-09-04149,443$1.07$160K
2026-09-0263,150$1.04$66K
2026-09-01241,582$1.09$263K
2026-08-316,599$1.08$7K
2026-08-28341,557$1.16$396K
2026-08-27313,096$1.06$332K
2026-08-26777,729$1.09$848K
2026-08-25524,869$1.04$546K
2026-08-24325,786$1.08$352K
2026-08-2134,217$0.93$32K
2026-08-201,886$0.88$2K
2026-08-17346,669$0.75$260K
2026-08-1310,520$0.82$9K
2026-08-1140$0.80$32
2026-08-106,541$0.85$6K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for UPXI in the last 90 days. The most recent filings are listed below. Latest filing: Salkind Gene (Director) on 2026-07-03.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-07-03Salkind GeneDirectorGrant100K$0.00$0319K
2026-07-03Rudick Brian BenjaminChief Strategy OfficerGrant400K$0.00$01.2M
2026-07-03Norstrud Andrew JamesChief Financial OfficerGrant400K$0.00$01.0M
2026-07-03MARSHALL ALLANChief Executive OfficerGrant2.0M$0.00$06.0M
2026-07-03Dugan LawrenceDirectorGrant100K$0.00$0216K
2025-12-23MARSHALL ALLANChief Executive OfficerBuy50K$1.80$90K4.0M
2025-12-16MARSHALL ALLANChief Executive OfficerBuy50K$2.07$104K4.0M
2025-12-15MARSHALL ALLANChief Executive OfficerBuy100K$2.07$207K3.9M
2025-11-20Salkind GeneDirectorBuy50K$2.55$128K219K
2025-11-17Salkind GeneDirectorBuy100K$2.65$265K569K
2025-11-17Salkind GeneDirectorBuy100K$2.81$281K169K
2025-10-01Norstrud Andrew JamesChief Financial OfficerGrant240K$0.00$0n/a
2025-10-01MARSHALL ALLANChief Executive OfficerGrant1.6M$0.00$03.8M
2025-07-22Dugan LawrenceDirectorBuy4K$7.50$30K116K
2025-07-16Dugan LawrenceDirectorGrant50K$0.00$0101K
2025-07-16Williams Thomas CharlesDirectorGrant50K$0.00$0100K
2025-07-16Norstrud Andrew JamesChief Financial OfficerGrant250K$0.00$0409K
2025-07-16MARSHALL ALLANChief Executive OfficerGrant1.2M$0.00$02.2M
2025-07-16Williams Thomas CharlesDirectorGrant50K$0.00$050K
2025-07-16Dugan LawrenceDirectorGrant50K$0.00$051K
2025-07-16Dugan LawrenceDirectorBuy1K$5.60$6K112K
2025-07-16Dugan LawrenceDirectorBuy10K$5.70$57K111K
2025-07-16Rudick Brian BenjaminCSOGrant400K$0.00$0839K
2025-07-16Salkind GeneDirector,TenPercentOwnerGrant50K$0.00$0435K
2025-07-16Salkind GeneDirector,TenPercentOwnerGrant150K$0.00$0585K
2025-07-15Dugan LawrenceDirectorBuy1K$5.17$5K1K
2025-07-11MARSHALL ALLANChief Executive OfficerBuy162K$4.94$800K1.0M
2025-07-11Salkind GeneDirector,TenPercentOwnerBuy20K$4.94$100K385K
2025-04-17Salkind GeneDirector,TenPercentOwnerBuy241K$2.28$550K365K
2025-04-17Norstrud Andrew JamesChief Financial OfficerGrant100K$0.00$0159K
2025-04-17Norstrud Andrew JamesChief Financial OfficerBuy44K$2.28$100K59K
2025-04-17MARSHALL ALLANChief Executive OfficerBuy658K$2.28$1.5M809K
2025-04-17MARSHALL ALLANChief Executive OfficerGrant75K$0.00$0884K
2024-03-12MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy64K$0.57$37K2.9M
2024-03-11MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy14K$0.60$8K2.9M
2024-03-05MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy103K$0.70$72K2.9M
2023-12-15MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy5K$0.91$4K2.8M
2023-12-14MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy8K$0.98$8K2.8M
2023-12-07MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy90K$0.94$85K2.8M
2023-12-05MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy19K$0.84$16K2.7M
2023-12-04MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy34K$0.71$24K2.6M
2023-06-28MARSHALL ALLANChief Executive OfficerBuy24K$2.26$54K2.7M
2023-06-27MARSHALL ALLANChief Executive OfficerBuy24K$2.39$57K2.7M
2023-06-26MARSHALL ALLANChief Executive OfficerBuy24K$2.43$58K2.6M
2023-06-23MARSHALL ALLANChief Executive OfficerBuy8K$2.39$19K2.6M
2023-06-22MARSHALL ALLANChief Executive OfficerBuy100$2.28$2282.6M
2023-05-22MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy23K$3.41$78K2.6M
2023-03-17MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy4K$4.41$18K2.6M
2023-03-16MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy5K$4.48$20K2.6M
2023-03-15MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy4K$4.33$19K2.6M
2022-12-16MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy5K$3.59$16K2.6M
2022-12-15MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy3K$3.66$10K2.6M
2022-12-14MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy10K$3.75$38K2.6M
2022-12-09MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy12K$4.11$49K2.6M
2022-12-01MARSHALL ALLANCHIEF EXECUTIVE OFFICERBuy18K$3.96$73K2.5M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

9 holders report 5% or more of UPXI in their latest filing, all on Schedule 13G (passive). The largest reported stake is Hivemind Capital Partners, LLC at 10.0% of the class (8,928,365 shares), filed 2026-08-14 for an event on 2026-06-30.

FiledFormHolderSharesOf classEvent
2026-08-1413G/Ano. 1Hivemind Capital Partners, LLCother entity8.9M10.0%2026-06-30
2026-08-1413G/Ano. 1Hivemind Validation QOZ GP LLCother entity8.9M10.0%2026-06-30
2026-08-1413G/Ano. 1Hivemind Validation Master Fund LPother entity8.9M10.0%2026-06-30
2026-08-1413G/Ano. 1Yechuan Zhangindividual8.9M10.0%2026-06-30
2026-07-3113G/Ano. 1Vanguard Capital Managementinvestment adviser2.7M3.9%2026-06-30
2026-07-2413G/Ano. 3Carlos Cristian Gilindividual2.2M3.1%2026-03-31
2026-07-2413G/Ano. 3Nadia Gilindividual2.2M3.1%2026-03-31
2026-07-2413G/Ano. 3CNC Inversiones Ltd.other entity2.2M3.1%2026-03-31
2026-07-2413G/Ano. 3GSR Growth Investments GP Ltd.partnership706K1.0%2026-03-31
2026-07-2413G/Ano. 3GSR Growth Investments LPpartnership706K1.0%2026-03-31
2026-07-2413G/Ano. 3GSR USA Intermediate LLCother entity55K0.1%2026-03-31
2026-07-2413G/Ano. 3GSR Strategies LLCother entity55K0.1%2026-03-31
2026-05-1513G/Ano. 2Polar Asset Management Partners Inc.investment adviser9.6M10.0%2026-03-31
2026-02-1313G/Ano. 1MMCAP International Inc. SPCcorporation6.3M10.0%2025-12-31
2026-02-1313G/Ano. 1MM Asset Management Inc.corporation6.3M10.0%2025-12-31
2026-02-1113G/Ano. 1Kathmere Capital Management, LLCinvestment adviser418K0.1%2025-09-30
2026-01-0813GMarex Securities Products Inc.corporation3.3M5.2%2026-01-05
2026-01-0813GMarex Group plcother entity3.3M5.2%2026-01-05
2025-10-1613GATTESTOR VALUE MASTER FUND LPpartnership00.0%2025-09-30
2025-10-1613GATTESTOR VALUE FUND GP LTDother entity00.0%2025-09-30
2025-10-1613GATTESTOR CAPITAL LTDother entity00.0%2025-09-30
2025-10-1613GATTESTOR Ltdinvestment adviser, other entity00.0%2025-09-30
2025-10-1613GPETERS JAN-CHRISTOPHindividual00.0%2025-09-30

13F holders

Tracked managers holding UPXI at their latest 13F. JSON

2 of the 30 tracked managers held UPXI at their latest 13F, $291K in total at quarter-end prices. Millennium Management is the largest at $213K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 1 cut.

FundQuarterSharesValueOf portfolioChange in shares
Millennium Management2026-06-30271K$213K0.00%-23K
Citadel Advisors2026-06-30100K$79K0.00%new

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Upexi in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Upexi (UPXI), SEC CIK 1775194, listed on Nasdaq, classified by the SEC as finance services. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-09-17.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-07-03.JSON and CSV
Company record
EDGAR filing index for CIK 1775194Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of UPXI is sold short?
11,720,613 shares were held short at the 2026-10-15 settlement, 5.3 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is UPXI's daily short volume?
On 2026-11-02, 193,605 of the 451,196 UPXI shares reported to FINRA were sold short, 42.9% of the day's reported volume. Short volume is a flow for one day, not a position.
Does UPXI have fails to deliver?
The SEC's latest file shows 60,114 UPXI shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.
Are UPXI insiders buying or selling?
No open-market insider trades were reported for UPXI in the last 90 days. The most recent filings are listed below. Latest filing: Salkind Gene (Director) on 2026-07-03.
Who owns 5% or more of UPXI?
9 holders report 5% or more of UPXI in their latest filing, all on Schedule 13G (passive). The largest reported stake is Hivemind Capital Partners, LLC at 10.0% of the class (8,928,365 shares), filed 2026-08-14 for an event on 2026-06-30.
Which tracked 13F managers own UPXI?
2 of the 30 tracked 13F managers held UPXI shares at their latest filing, $291K in all. The largest: Izzy Englander's Millennium Management (271K shares, $213K), Ken Griffin's Citadel Advisors (100K shares, $79K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.